title: Intra-arterial injection, a rare but serious complication of sclerotherapy.
abstract: Intra-arterial injections represent the most feared complication of sclerotherapy for varicose veins. We present a case of an inadvertent intra-arterial injection of polidocanol at the left medial calf in a 59-year-old woman with subsequent arterial occlusions of the posterior tibial artery and foot arteries. Despite several therapeutic interventions, lower-limb amputation could not be prevented. We conducted a PubMed search for articles reporting arterial complications related to sclerotherapy, in order to evaluate aetiology, clinical presentation, therapeutic management and outcome of sclerotherapy-associated intra-arterial injections during the past 50 years. Intra-arterial injection of a sclerosing solution was reported in 63 cases, mostly after injection near the ankle region or the distal medial calf. Clinical presentation was frequently characterized by immediate pain during injection and distal ischaemia with subsequent tissue loss. Despite several treatment approaches, amputation could not be prevented in 31 cases (52.5%). The pathophysiology of arterial complications related to intra-arterial injection and advisable therapeutic interventions are discussed. Inadvertent intra-arterial injection represents a limb-threatening complication of sclerotherapy. Target-oriented and prompt therapy seems inevitable in order to reduce the risk of permanent tissue loss and amputation.
authors.affiliation: Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
authors.forename: F
authors.initials: F
authors.lastname: Hafner
authors.forename: H
authors.initials: H
authors.lastname: Froehlich
authors.forename: T
authors.initials: T
authors.lastname: Gary
authors.forename: M
authors.initials: M
authors.lastname: Brodmann
mesh_terms: D001157:Arterial Occlusive Diseases / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D008875:Middle Aged; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects*; D015911:Sclerotherapy / Q000009:adverse effects*; D016909:Tibial Arteries / Q000473:pathology / Q000503:physiopathology; D014648:Varicose Veins / Q000473:pathology / Q000503:physiopathology / Q000628:therapy
chemical_list: D012597:Sclerosing Solutions